Skip to main content
Equibles
ABSI logo

ABSI · Absci Corp · Metrics

Track ABSI — free

Use ABSI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABSI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.45 -0.20 (-2.31%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.48B
Shares
171.61M

ABSI metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.65
Market cap
$1.48B

Price action

20 metrics
Price change (1W)
+0.8%
Price change (30D)
-1.1%
Price change (3M)
+30.5%
Price change (6M)
+250.8%
Price change (YTD)
+155.3%
Price change (1Y)
+255.0%
Trailing year
Price change (5Y)
-37.6%
52-week high
$11.62
52-week low
$2.30
Change from 52-week high
-23.3%
Change from 52-week low
+287.4%
Annualized volatility
106.3%
Annualized volatility (3M)
111.2%
Beta
3.4
RSI (14D)
49.6
Price vs SMA 50
-3.2%
Price vs SMA 200
+68.0%
Avg volume (3M)
4.65M
Relative volume
0.5
Average dollar volume
$42.90M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
171.61M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
969.7×
reciprocal yield 0.1%
P / book
6.1
reciprocal yield 16.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
68.6×
reciprocal yield 1.5%
EV / revenue historical average (5Y)
61.7×
reciprocal yield 1.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
—
Operating margin
-8,084.5%
Trailing 12 months
Net margin
-7,756.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$126.20M
Net income (TTM)
−$121.08M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.55

Growth

11 metrics
Revenue growth YoY
-46.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.56M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+23.4%
Year over year · more shares
Revenue CAGR (3Y)
-21.3%
Revenue CAGR (5Y)
-10.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-49.2%
Return on assets
-45.0%
Debt / equity
—
Current ratio
10.6
EBITDA (TTM)
−$115.11M
Free cash flow (TTM)
—
Quick ratio
10.6
Interest coverage
-1,342.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$107.86M
Total assets
$268.92M
Total debt
$3.99M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$108.08M
Capital expenditures (TTM)
$890,000
R&D (TTM)
$86.49M
SG&A (TTM)
$35.28M
Stock compensation (TTM)
$18.28M
R&D / revenue
5,540.5%
Stock compensation / revenue
1,170.8%

Ownership (13F)

3 metrics
13F filers
200
13F filer change QoQ
+36
Institutional ownership
89.8%

Short interest

3 metrics
Short interest
21.8%
Latest settlement · 15.2 days to cover
Days to cover
15.2d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
$148,866
Insider-sentiment score
79 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1672688 CUSIP 00091E109 13F (30d) 126 filings 126 filers Visit website Investor relations